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Patient Room Decontamination against
Carbapenem-Resistant Enterobacteriaceae and
Methicillin-Resistant Staphylococcus aureus
Using a Fixed Cycle-Time Ultraviolet-C Device
and Two Different Radiation Designs
The contaminated surface environment of hospital rooms
has been demonstrated to be a source of patient-to-patient
transmission of multidrug-resistant organisms (MDROs),
including methicillin-resistant Staphylococcus aureus
(MRSA).1,2 MDROs can survive on surfaces for days to weeks
(for months in some cases).3 Following terminal room
cleaning and disinfection, frequent contamination by these
pathogens has been reported.1,2 Patients admitted to a room
where the previous occupant was also colonized or infected
with an MDRO are at substantial risk for acquisition of this
MDRO.4 For these reasons, “no-touch” methods of room
disinfection have been evaluated, including devices that emit
ultraviolet (UV) light or produce hydrogen peroxide vapor.5
Use of UV devices has been demonstrated to reduce
healthcare-associated pathogens.5
Carbapenem-resistant Enterobacteriaceae (CRE) are a
growing problem in the United States and worldwide.6 CRE
infections are difficult to treat and have been associated
with substantial mortality. Frequent contamination of room
surfaces near CRE carriers has been described.7 For this
reason, we assessed the efficacy of a UV-C device to inactivate
MRSA and CRE. We also assessed whether 2 cycles of the
device (in which 1 cycle was completed on the right side of the
bed and 1 cycle on the left side of the bed) were superior to a
single cycle (in which the device was placed at the foot of
the bed).
In this study, we evaluated the Optimum UV (Clorox,
Pleasanton, CA), a fixed cycle-time UV-C (254 nm) device
with four 157-cm lamps in an unoccupied patient room
(24.76m2). To assess the efficacy of 2 different decontamina-
tion methods, the UV-C device was placed either at the end of
the bed in the center of room in a single cycle (design A) or at
both sides of the bed in the center of room with a single cycle at
the right side and another cycle at left side (design B). The cycle
time of the device for room decontamination was fixed at
5 minutes. Each design was tested in triplicate. Locations
where test Formica sheets were placed were categorized as the
UV-C direct group (laser point visible on site) or the UV-C
indirect group (laser point not visible on site). Testing was
performed using clinical isolates of MRSA and carbapenem-
resistant Klebsiella pneumoniae (CRKP). A 10–15 µL inoculum
containing ~106–107 test organisms per replicate organism
detection and counting (Rodac) template was spread
separately on each Formica sheet using a sterile glass hockey
loop. Inoculated Formica sheets were placed and attached with
tape in the following 10 locations throughout the room for
both designs: (1) the back of the computer (indirect/indirect);
(2) the side of the sink counter (indirect/direct); (3) the
vertical end of the foot of the bed (direct/indirect); (4) the
horizontal top of the bed (direct/direct); (5) the vertical back
of the visitor’s chair (indirect/indirect); (6) the horizontal
counter in front of the refrigerator (direct/direct); (7) the
vertical end of the head of the bed (indirect/indirect); (8) the
vertical side of the bedside table facing the window (indirect/
indirect); (9) the horizontal top of the toilet rim in the
bathroom (indirect/indirect); and (10) the horizontal top of
the couch table (direct/direct). After UV-C cycle completion,
each Formica sheet was cultured using Rodac plates containing
Day-Engley (DE) neutralizing agar. These plates were
incubated aerobically at 37°C for 48 hours for CRKP and
MRSA. The colony-forming units (CFU) of the test organisms
on each plate were then counted. When Rodac plates had
confluent growth, the number of CFUs per plate was set at 300
for analysis. Statistical significance was determined by paired
t test; P< .05 was considered significant.
Overall, in an unoccupied patient room, we observed a
5.01-log10 reduction using design A and a 5.87-log10 reduction
using design B for decontamination of CRKP (P= .0003). We
observed a 4.61-log10 reduction and a 5.06-log10 reduction for
MRSA (P= .0418) (Table 1). At UV-C direct sites, we
measured an additional 0.87-log10 reduction using design B
for CRKP (P= .0028) and an additional 0.55-log10 reduction
for MRSA (P> .05) compared with design A. When we
assessed the correlation of log10 reduction (in direct line of
sight) to distance, there was a strong correlation (r=− 0.826,
P= .0009 for CRKP and r=− 0.842, P= .0006 for MRSA);
however, we detected a ≥ 4.89-log10 reduction for CRKP and a
≥4.19-log10 reduction for MRSA at the farthest distance
(2.69m). At UV-C indirect sites, we measured an additional
0.86-log10 reduction using design B for CRKP (P= .0002) and
an additional 0.38-log10 reduction for MRSA (P= .0113)
compared to design A. The frequency of too-numerous-
to-count (TNTC) cultures was as follows: MRSA 42%
(25 of 60) and CRKP 32% (19 of 60). Data for microbial
inactivation without TNTC results are shown in the
Supplemental Material.
Our study demonstrated that the fixed-time UV-C device
evaluated in this study was effective in 5–10 minutes in
eliminating >5-log10 MRSA and CRKP when the surfaces were
in direct line of sight of the UV-C device and >4-log10 MRSA
and CRKP when the surfaces were in indirect line of sight.
These results are similar to those we have previously
published.8 While the use of 2 cycles of the device with
placement at either side of the bed for 1 cycle each often
resulted in significantly improved inactivation of the vegetative
MDROs studied (ie, MRSA, CRKP), a single cycle was highly
effective, and the difference is likely not clinically meaningful.
Given the frequency of TNTC cultures, our level of microbial
kill should be considered a maximum level.
We are aware of several limitations of this study. First, we
only inoculated Formica sheets. Our previous study revealed
that CRE survived poorly not only on fabrics but also on hard
surfaces such as Formica and steel.9 Second, the size of our
study limited our ability to perform subgroup analyses such as
inactivation in direct versus indirect line of sight.
In this study, we tested a clinical CRE strain because of
the global concern regarding its morbidity and mortality.
Importantly, the present study demonstrated that UV-C room
decontamination was effective against CRE. The role of hos-
pital environmental surfaces in CRE transmission remains
controversial: CRE was infrequently (8%) isolated from
environmental surfaces in rooms housing CRE colonized/
infected patients in our previous study,9 while CRE
contamination of hospital environment was frequently (88%)
identified at surrounding sites among patients with this
organism by an Israeli study.7
In conclusion, the present data and our previous findings
have demonstrated that UV-C devices can effectively decon-
taminate hospital surfaces contaminated with MDROs,
including CRE. In this experiment, 2 cycles of a UV-C device
were often statistically superior to a single cycle, but both
designs are likely to be clinically effective (>2-log10 reduction)
because epidemiologically important pathogens measured in
hospital room surfaces were <100 CFU/Rodac (<2-log10).
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